Sanne G Swinnen

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. doi request reprint The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back
    S G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, Meibergdreef 9, Amsterdam, The Netherlands
    Diabetologia 51:1790-5. 2008
  2. doi request reprint Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia
    S G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, AZ, Amsterdam, The Netherlands
    Diabetologia 52:38-41. 2009
  3. doi request reprint Higher dose requirements with insulin detemir in type 2 diabetes--three cases and a review of the literature
    Sanne G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands
    Diabetes Res Clin Pract 84:e24-6. 2009
  4. pmc Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes
    S G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Diabetologia 52:2324-7. 2009
  5. doi request reprint Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes
    Sanne G H A Swinnen
    Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Diabetes Technol Ther 11:739-43. 2009
  6. pmc A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs
    Sanne G Swinnen
    Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Diabetes Care 33:1176-8. 2010
  7. ncbi request reprint Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Sanne G Swinnen
    Internal Medicine, Academic Medical Centre, Meibergdreef9, Amsterdam, Netherlands, 1105 AZ
    Cochrane Database Syst Rev 7:CD006383. 2011

Detail Information

Publications8

  1. doi request reprint The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back
    S G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, Meibergdreef 9, Amsterdam, The Netherlands
    Diabetologia 51:1790-5. 2008
    ....
  2. doi request reprint Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia
    S G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, AZ, Amsterdam, The Netherlands
    Diabetologia 52:38-41. 2009
    ..The aim of this analysis was to quantify the relationship between the frequency of hypoglycaemia and various glucose cut-off points for the definition of hypoglycaemia, within a range of HbA(1c) strata...
  3. doi request reprint Higher dose requirements with insulin detemir in type 2 diabetes--three cases and a review of the literature
    Sanne G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands
    Diabetes Res Clin Pract 84:e24-6. 2009
    ..Meta-analysis of three randomised trials of basal insulin initiation confirmed this increased insulin detemir dose requirement in type 2 patients. Potential explanations are discussed...
  4. pmc Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes
    S G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Diabetologia 52:2324-7. 2009
    ..The aim of the present study was to investigate whether predetermined contact frequency with the study team and endpoint insulin dose are associated with study outcomes in basal insulin initiation trials in type 2 diabetes...
  5. doi request reprint Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes
    Sanne G H A Swinnen
    Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Diabetes Technol Ther 11:739-43. 2009
    ....
  6. pmc A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs
    Sanne G Swinnen
    Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Diabetes Care 33:1176-8. 2010
    ..To determine whether glargine is noninferior to detemir regarding the percentage of patients reaching A1C <7% without symptomatic hypoglycemia <or=3.1 mmol/l...
  7. ncbi request reprint Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Sanne G Swinnen
    Internal Medicine, Academic Medical Centre, Meibergdreef9, Amsterdam, Netherlands, 1105 AZ
    Cochrane Database Syst Rev 7:CD006383. 2011
    ..Several reviews have compared either insulin detemir or insulin glargine to NPH insulin, but research directly comparing both insulin analogues is limited...